|
|
???tair.name??? >
???browser.page.title.author???
|
"chou cheng yang"???jsp.browse.items-by-author.description???
Showing items 1-10 of 103 (11 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-06-17T02:03:04Z |
Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study
|
Chou, Cheng-Yang; WEN-FANG CHENG; Chen, Min-Yu; Lin, Hao; Ho, Chih-Ming; Hung, Yao-Ching; Huang, Lee-Wen; Wang, Po-Hui; Yu, Mu-Hsien; Huang, Yu-Fang |
| 嘉南藥理大學 |
2021 |
COL11A1 activates cancer-associated fibroblasts by modulating TGF-beta 3 through the NF-kappa B/IGFBP2 axis in ovarian cancer cells
|
Wu, Yi-Hui; Huang, Yu-Fang; Chang, Tzu-Hao; Chen, Chien-Chin; Wu, Pei-Ying; Huang, Soon-Cen; Chou, Cheng-Yang |
| 國立成功大學 |
2020-07-14 |
Real-world Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-line or Relapse Therapy (ROBOT): 8-year Experience
|
黃于芳; Huang, Yu-Fang; Wu, Pei-Ying;Cheng, Ya-Min;Shen, Meng-Ru;Chen, Yi-Chun;Chou, Cheng-Yang |
| 國立交通大學 |
2020-03-03 |
Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
|
Chou, Cheng-Yang; Huang, Chia-Yen; Chen, Chien-Chin; Wu, Yi-Hui; Huang, Yu-Fang |
| 國立成功大學 |
2020-02-21 |
Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca2+ entry-mediated turnover of focal adhesions
|
邱文泰; CHIU, WEN-TAI;Huang, Ho-Kai;Lin, Yi-Hsin;Chang, Heng-Ai;Lai, Yi-Shyun;Chen, Ying-Chi;Huang, Soon-Cen;Chou, Cheng-Yang |
| 嘉南藥理大學 |
2020 |
Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
|
Wu, Yi-Hui; Huang, Yu-Fang; Chen, Chien-Chin; Huang, Chia-Yen; Chou, Cheng-Yang |
| 國立成功大學 |
2019-04-01 |
Akt Inhibitor SC66 Promotes Cell Sensitivity to Cisplatin in Chemoresistant Ovarian Cancer Cells Through Inhibition of COL11A1 Expression
|
黃于芳; Huang, Yu-Fang; Wu, Yi-Hui;Chen, Chien-Chin;Chou, Cheng-Yang |
| 嘉南藥理大學 |
2019 |
Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression
|
Wu, Yi-Hui; Huang, Yu-Fang; Chen, Chien-Chin; Chou, Cheng-Yang |
| 國立成功大學 |
2019 |
A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy
|
黃于芳; Huang, Yu-Fang; Kuo, MacUs Tien;Liu, Yi-Sheng;Cheng, Ya-Min;Wu, Pei-Ying;Chou, Cheng-Yang |
| 臺大學術典藏 |
2018-09-10T15:28:31Z |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
Chen, Yu-Li;Chou, Cheng-Yang;Chang, Ming-Cheng;Lin, Han-Wei;Huang, Ching-Ting;Hsieh, Shu-Feng;Chen, Chi-An;Cheng, Wen-Fang; Chen, Yu-Li;Chou, Cheng-Yang;Chang, Ming-Cheng;Lin, Han-Wei;Huang, Ching-Ting;Hsieh, Shu-Feng;Chen, Chi-An;Cheng, Wen-Fang; Chen, Y.-L. and Chou, C.-Y. and Chang, M.-C. and Lin, H.-W. and Huang, C.-T. and Hsieh, S.-F. and Chen, C.-A. and Cheng, W.-F.; 鄭文芳;陳祈安;陳玉怜; 鄭文芳;陳祈安;陳玉怜; CHI-AN CHEN; Chen, Yu-Li; Chen, Yu-Li; Chou, Cheng-Yang; Chou, Cheng-Yang; Hsiao, Chen-Hsi; Chang, Ming-Cheng; Lin, Han-Wei; Lin, Han-Wei; Huang, Ching-Ting; Hsieh, Shu-Feng; Chen, Chi-An; Chen, Chi-An; Cheng, Wen-Fang; Cheng, Wen-Fang; ????? |
Showing items 1-10 of 103 (11 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
